As previously mentioned, metformin is recommended as a first-line agent in the treatment of impaired glucose tolerance and type 2 diabetes mainly because of its ability to reduce hepatic glucose production and increase insulin-stimulated glucose uptake in muscle and fat [1,2,5]. The gene discussed is INS; the disease is type 2 diabetes mellitus.